ZimVie (NASDAQ:ZIMV) Sees Large Volume Increase - Should You Buy?

Shares of ZimVie Inc. (NASDAQ:ZIMV - Get Free Report) saw unusually-strong trading volume on Tuesday . Approximately 415,192 shares traded hands during mid-day trading, an increase of 87% from the previous session's volume of 221,832 shares.The stock last traded at $18.74 and had previously closed at $18.76.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on ZIMV shares. B. Riley assumed coverage on ZimVie in a research report on Thursday, April 10th. They issued a "buy" rating and a $16.00 price target for the company. Barclays upgraded ZimVie from an "underweight" rating to an "equal weight" rating and boosted their price objective for the company from $9.00 to $19.00 in a research note on Tuesday. UBS Group cut their price objective on ZimVie from $16.00 to $10.00 and set a "neutral" rating for the company in a research note on Thursday, May 15th. Needham & Company LLC reiterated a "hold" rating on shares of ZimVie in a research note on Wednesday, April 9th. Finally, Wall Street Zen downgraded ZimVie from a "strong-buy" rating to a "buy" rating in a research note on Friday. Three analysts have rated the stock with a hold rating, one has assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $17.00.

ZimVie Stock Up 0.2%

The company has a fifty day moving average of $9.05 and a two-hundred day moving average of $10.90. The company has a market cap of $523.44 million, a PE ratio of -26.47 and a beta of 2.07. The company has a debt-to-equity ratio of 0.58, a quick ratio of 1.48 and a current ratio of 2.14.

ZimVie (NASDAQ:ZIMV - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported $0.27 earnings per share for the quarter, topping analysts' consensus estimates of $0.21 by $0.06. ZimVie had a positive return on equity of 5.53% and a negative net margin of 4.40%. The business had revenue of $112.00 million for the quarter, compared to analyst estimates of $113.10 million. As a group, analysts anticipate that ZimVie Inc. will post 0.6 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the stock. AlphaQuest LLC boosted its stake in ZimVie by 2,695.9% during the first quarter. AlphaQuest LLC now owns 8,947 shares of the company's stock worth $97,000 after buying an additional 8,627 shares during the last quarter. Quantbot Technologies LP purchased a new stake in ZimVie in the first quarter valued at $98,000. Jones Financial Companies Lllp raised its position in ZimVie by 9,039.1% in the first quarter. Jones Financial Companies Lllp now owns 12,612 shares of the company's stock valued at $136,000 after purchasing an additional 12,474 shares during the period. Hsbc Holdings PLC acquired a new position in ZimVie during the 1st quarter worth about $144,000. Finally, Wealth Enhancement Advisory Services LLC boosted its holdings in ZimVie by 8.2% during the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 15,808 shares of the company's stock valued at $162,000 after acquiring an additional 1,194 shares during the period. 95.63% of the stock is currently owned by hedge funds and other institutional investors.

About ZimVie

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.